CORESTA Congress, Sapporo, 2012, Smoke Science/Product Technology Groups, SS 02
Development of a systems toxicology approach and its application to quantify the biological impact of tobacco smoke in vitro and in vivo
Philip Morris International R&D, Philip Morris Products SA, Neuchâtel, Switzerland
The potential health risks of long-term exposure to biologically active substances such as therapeutic drugs or environmental toxins are frequently determined a posteriori through clinical epidemiology studies. However, disease may take decades to ...